| Title of Invention | PHOSPHONIC ACID COMPOUNDS AS INHIBITORS OF SERINE PROTEASES |
|---|---|
| Abstract | The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders (FIG.nil). |
| Full Text |
|---|
625-kolnp-2004-granted-abstract.pdf
625-kolnp-2004-granted-claims.pdf
625-kolnp-2004-granted-correspondence.pdf
625-kolnp-2004-granted-description (complete).pdf
625-kolnp-2004-granted-drawings.pdf
625-kolnp-2004-granted-examination report.pdf
625-kolnp-2004-granted-form 1.pdf
625-kolnp-2004-granted-form 18.pdf
625-kolnp-2004-granted-form 2.pdf
625-kolnp-2004-granted-form 26.pdf
625-kolnp-2004-granted-form 3.pdf
625-kolnp-2004-granted-form 5.pdf
625-kolnp-2004-granted-letter patent.pdf
625-kolnp-2004-granted-reply to examination report.pdf
625-kolnp-2004-granted-specification.pdf
| Patent Number | 219900 | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indian Patent Application Number | 00625/KOLNP/2004 | ||||||||||||||||||||||||||||||||||||
| PG Journal Number | 20/2008 | ||||||||||||||||||||||||||||||||||||
| Publication Date | 16-May-2008 | ||||||||||||||||||||||||||||||||||||
| Grant Date | 14-May-2008 | ||||||||||||||||||||||||||||||||||||
| Date of Filing | 13-May-2004 | ||||||||||||||||||||||||||||||||||||
| Name of Patentee | ORTHO-MCNEIL PHARMACEUTICAL, INC. | ||||||||||||||||||||||||||||||||||||
| Applicant Address | 202,, RARITAN NJ 08869 USA. | ||||||||||||||||||||||||||||||||||||
Inventors:
|
|||||||||||||||||||||||||||||||||||||
| PCT International Classification Number | C07F9/08 | ||||||||||||||||||||||||||||||||||||
| PCT International Application Number | PCT/US02/33206 | ||||||||||||||||||||||||||||||||||||
| PCT International Filing date | 2002-10-17 | ||||||||||||||||||||||||||||||||||||
PCT Conventions:
|
|||||||||||||||||||||||||||||||||||||